Efficacy and Safety Study of DHA-O in Adults With Hypertriglyceridemia (DHA-O)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
18 Years to 79 Years (Adult, Older Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
fasting TG levels, 150-499 mg/dL
baseline DHA intake <200mg/d
active and in good health
recent diagnosis of CHD or history of revascularization within 6mos of study
use of lipid altering medications (other than stable statins)
use of anticoagulants
use of omega-3 products within 4 weeks of screening
serum AST/ALT >1.5x ULN and/or creatinine >1.5 mg/dL at screening
lipid altering foods or supplements
women who are pregnant or of childbearing potential not using adequate birth control